3Niwa T.Dialysis-related amyloidosis:pathogenesis focusing on AGE modification.Semin Dial,2001,14(2):114 ～ 125.
4Bonnardel-Phu E.Wantier IL,Vicaut E,et al.Advanced glycation end products are involved in microvascular permeability changes observedin microcirculation of diabetic rats in vivo.7 Mal vasc,2000,25 (2):122～127.
7Kikuchi S, Shinpo K, Takeuchi M, et al. Glycation-a sweet tempter for neuronal death[J]. Brain Res Reviews, 2003, 41:306-323.
8Stracke H, Hammes HP, Werkmann D, et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats [J]. Exp Clin Endocrinol Diabetes, 2003,109:330-336.
9Haslbeck KM, Schleicher ED, Friess U, et al. N(epsilon)-Carboxy-methyllysine in diabetic and non-diabetic polyneuropathies[J]. Acta Neuropathol, 2002, 104:45-52.
10Wada R, Nishizawa Y, Yagihashi N, et al. Effects of OPB-9195, anti-glycation agent,on experimental diabetic neuropathy[J]. Eur J Clin Invest,2001,31:513-520.
